May 12, 2026

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

Conexiant

May 12, 2026

Late Preterm Steroids: No Lung Benefit

Follow-up of the ALPS trial found similar rates of respiratory impairment at age 6 years or older with betamethasone vs placebo

Conexiant

May 11, 2026

Stewardship Cuts Steroid Prescribing

Behaviorally informed peer comparison feedback was associated with a gradual decline in glucocorticoid prescribing

Conexiant

May 11, 2026

Health, Social Needs Tied to Absences

National survey data suggest overlapping chronic health and social needs are associated with higher rates of illness-related missed school days among US children.

Conexiant

May 08, 2026

Not All Lung Bacteria Are the Enemy

Cross-disease meta-analysis also found modest associations with lung function, though findings varied by disease type

Conexiant

May 08, 2026

Fabricated Citations Are Reaching Medical Journals

A large audit of biomedical publications suggests fabricated references are increasingly appearing in peer-reviewed papers — often in ways that are difficult for reviewers and readers to detect.

Conexiant

May 05, 2026

Smartwatch May Track AD Status in Children

Wearable-derived scratching measures align with disease activity and short-term treatment response in pediatric patients with atopic dermatitis.

Conexiant

May 05, 2026

Low Follow-Up After Behavioral ED Care

Follow-up occurred after fewer than 15% of mental health ED visits and about 11% of substance use–related visits in Washington Medicaid claims.

Conexiant

May 05, 2026

AAP Updates Pediatric Office Emergency Readiness

Guidance addresses office readiness, recommended equipment and medications, and team communication processes for infrequent but high-acuity emergencies.

Conexiant

May 04, 2026

FDA Expands ASCENIV Pediatric Use

Label change follows completion of required pediatric evaluation and updates prior age restrictions for treatment eligibility.

Conexiant